Shavit Capital Fund

Shavit Capital Fund Overview

Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies. Shavit Capital has over $400 million under management across five separate private equity funds. The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange. Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies. Shavit Capital is well positioned to pursue investments that are not suitable for its Funds. With its strong investor base, Shavit Capital has built a platform that facilitates investments in leading Israeli companies and supports them in different stages of their financial needs. In particular, Shavit Capital is interested in taking significant non-controlling interests in late stage companies, whether private or public. Shavit Capital's fifth fund was raised in 2018.

Latest News

Oct 31, 2018 · en.globes.co.il

growth-positive

Shavit Capital raises $100m for fifth fund

Shavit Capital, founded and managed by Gary Leibler, has completed a $100 million funding round for its fifth fund. The firm specializes in pre-IPO investments in life-sciences companies, with a focus on the technology sector. Shavit Capital plans to expand its activities to include companies nearing flotation in other markets. It works closely with leading international investment banks and leads investment rounds ranging from $20 million to $60 million. The firms portfolio includes companies like Foamix Pharmaceuticals, Kamada, and PolyPid. Shavit Capitals recent notable funding round was a $40 million round for Gamida Cell, which completed an IPO on Nasdaq and raised $50 million. The firms partners include Leon Recanati, Jonathan Leibler, Gabriel Menaged, and Erez Yuval.

InvestmentExpand

May 19, 2015 · www.globes.co.il

growth-positive

Shavit Capital raises $75m Israel start-up fund

Shavit Capital Fund, headed by managing director Gary Leibler, has raised $75 million from investors mainly from the US. The fund will invest at least 50% of its money in biomed. The previous funds managed by Shavit Capital invested in companies such as ReWalk Robotics, Foamix Pharmaceuticals, SuperDerivatives, Kamada Ltd., and Brainsway Ltd. The new fund is expected to operate according to a unique model of a minority investment without any demand for a place on the board of directors. Shavit Capitals success depends on a continued active window for offerings.

Investment

Team Members

7

Web & Social Links

Locations

Derech Agudat Sport HaPo'el 1, Jerusalem, Israel

Photos & Videos

No files yet

Shavit Capital Fund Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info